Table 4.
Outcome scores for each group at baseline (week 0), post-intervention (week 4), follow-up (week 8), and follow-up 2 (week 12): mean and standard deviation.
Outcome Measure | Hip Group | Quadriceps Group | Control | F | p | Post Hoc |
---|---|---|---|---|---|---|
Mean (SD) | Mean (SD) | Mean (SD) | ||||
Flexion ROM | ||||||
Baseline | 114.42 ± 10.52 | 115.15 ± 9.33 | 117 ± 5.79 | 0.378 | 0.687 | |
4 week f/w | 118.32 ± 9.39 | 120.4 ± 7.25 | 118.44 ± 5.66 | 5.8 | 0.005 * | B > C |
8 week f/w | 119.53 ± 9.19 | 121.45 ± 6.73 | 118.56 ± 5.64 | 9.274 | 0.001 * | A, B > C |
12 week f/w | 119.84 ± 8.82 | 122.7 ± 6.4 | 118.88 ± 5.62 | 11.006 | 0.001 * | A, B > C |
Time × Group | 3.382 | 0.004 * | ||||
Extension ROM | ||||||
Baseline | 10.37 ± 5.6 | 8.1 ± 3.58 | 9.13 ± 3.09 | 1.371 | 0.263 | |
4 week f/w | 8.58 ± 4.76 | 6.8 ± 2.72 | 8.19 ± 2.56 | 1.509 | 0.231 | |
8 week f/w | 7.79 ± 4.41 | 6.2 ± 2.3 | 8 ± 2.65 | 4.776 | 0.013 * | A, B > C |
12 week f/w | 7.84 ± 4.11 | 6.1 ± 2.33 | 7.63 ± 2.6 | 2.604 | 0.084 | |
Time × Group | 2.291 | 0.041 * | ||||
WOMAC-P | ||||||
Baseline | 12.32 ± 2.42 | 12.75 ± 2.78 | 12.19 ± 2.56 | 0.239 | 0.788 | |
4 week f/w | 8.21 ± 4.14 | 10.1 ± 2.97 | 11.25 ± 1.91 | 6.547 | 0.003 * | A > C |
8 week f/w | 8.37 ± 2.56 | 9.6 ± 2.41 | 11 ± 2.12 | 11.474 | 0.001 * | A, B > C |
12 week f/w | 8.05 ± 3.2 | 9.8 ± 2.39 | 10.69 ± 2.15 | 7.677 | 0.001 * | A > C |
Time × Group | 3.493 | 0.004 * | ||||
WOMAC-F | ||||||
Baseline | 41.89 ± 5.36 | 45.1 ± 7.13 | 45.31 ± 4.78 | 1.931 | 0.155 | |
4 week f/w | 33.74 ± 8.93 | 38.2 ± 6.38 | 43.56 ± 3.75 | 8.464 | 0.001 * | A, B > C |
8 week f/w | 33.32 ± 8.49 | 37.35 ± 5.94 | 41.5 ± 4.32 | 5.767 | 0.006 * | A > C |
12 week f/w | 32.05 ± 8.76 | 36.75 ± 5.32 | 40.31 ± 4.84 | 5.499 | 0.007 * | A > C |
Time × Group | 1.456 | 0.201 |
SD, standard deviation; ROM, range of motion; WOMAC, Western Ontario and McMaster Universities Osteoarthritis Index. * p < 0.05.